PKS Holdings (PKS) TRADING HALT SUSPENDED

20mins delayed

Movement

1 Year Return

System message

16 Sept 2019: Updates have been made to Broker Consensus and Highest Dividends.

Get these alerts in your email: Signup Free Here

PKS Holdings Chart

Share price
Last
Change
Volume
Turnover
Market Cap $21.81 million
Today's Movement
Prev. Close
Open
Day Range -
VWAP
Historical Stats
52w Range -
4w Avg Volume
4w Avg Turnover
(delayed)

PKS Statistics

17 September

1,398 / 2,298

ASX Size Rank

1yr Return

vs Sector (1yr)

-11.35%

vs ASX 200 (1yr)

-8.25%

$21.81 million

Market Cap

Share Issue

121.14 million

All Ords (%)

N/A

Short Sold

0%

Current Fundamentals

17 September

N/A

PE Ratio

EPS ($)

-

Earnings Yield

-

NTA ($)

-

N/A

Dividend Yield

DPS ($)

-

Gross Div. Yield

-

Gross DPS ($)

-

Company Overview

PKS Holdings Limited (PKS) is an Australian healthcare technology company. It provides a proprietary subscription based Clinical Decision Support system (CDS) called "RippleDown". A CDS is a health information technology system that is designed to provide health professionals with assistance in clinical decision making tasks.PKS works with health organisations around the world to better capture, manage and leverage their human expertise to improve the performance of their business and deliver better patient outcomes. PKS supports health organisation capture critical information in an accurate, consistent and reliable manner, across multiple data sources. By applying clinical expertise to all data in real-time.

PKS Holdings Logo

Corporate Details

Head Office: Sydney
Managing Director: Ronald Van der Pluijm
GICS Sub-Industry: Health Care Technology
Date Listed: 6 Jun 2019
Registry: -
Similar Companies: PME / ONE / VHT / OHE / RAP

Upcoming Calendar

28 Aug 2020 Report (Prelim)
28 Aug 2020 Report (Annual)

Dividend History

Ex-Date Amount Franking Type Payable
No dividends paid in the last 5 years

See Upcoming Dividends for all ASX companies.

Announcements

Date Heading Pages File Size Time

Broker Consensus

The buy, hold and sell recommendations from Australian stockbroking firms are combined to form a "broker consensus". See the Consensus Data posts for more information.

PKS is not covered by a major broker.

Directors & Management

About the Data


Name Title Since Bio
Mr Paul Williams Non-Executive Director May 2019
Mr Andrew Gray Non-Executive Director May 2019
Mr Neil John Broekhuizen Non-Executive Director May 2019
Mr Michael (Mike) Hastings Hill Non-Executive Chairman, Non-Executive Director Jun 2018
Mr Ronald Van der Pluijm Chief Executive Officer, Managing Director May 2019

Director Transactions

About the Data

PKS directors must report any change in shareholding to the ASX within 5 business days.

See Director Transactions for all ASX companies.

There are no director transactions for code PKS in our database.

Shareholder Distribution

Shareholder Distribution data is unavailable.

Top 20 Shareholders

About the Data

Name Shares Capital
HSBC Custody Nominees (Australia) Limited 10,560,000 8.72%
National Nominees Limited 9,250,000 7.64%
Bombora Investment Management Pty Ltd 8,700,000 7.18%
Mirrabooka Investments Limited 5,500,000 4.54%
CS Third Nominees Pty Limited 5,000,000 4.13%
Mr Christopher Bell 2,499,000 2.06%
Morgan Stanley Australia Securities (Nominee) Pty Limited 2,000,000 1.65%
Jasforce Pty Ltd 1,500,000 1.24%
Mace Group Pty Limited 1,400,000 1.16%
Caladan Capital Pty Ltd 1,250,000 1.03%
Jaspar Discretionary Family Trust Pty Ltd 1,250,000 1.03%
RJWH Holdings Pty Limited 1,250,000 1.03%
Shorebrook Pty Ltd 1,000,000 0.83%
Haydalex Pty Ltd Atf Haydalex Super 1,000,000 0.83%
HSBC Custody Nominees (Australia) Limited A/C 2 1,000,000 0.83%
Golden Words Pty Ltd 1,000,000 0.83%
Marshall Investments Pty Ltd 750,000 0.62%
Gurravembi Investments Pty Ltd 750,000 0.62%
Mr Anthony Shane Kittel & Mrs Michele Therese Kittel 625,000 0.52%
Malolo Holdings Pty Ltd 625,000 0.52%
Tigershark Investment Pty Ltd 600,000 0.50%
Mrs Xiaoling Ruan 550,000 0.45%
Mr Simon Ling 500,289 0.41%
Mr Andrew Macbride Price 500,000 0.41%
Mr Steven Robert Budd 500,000 0.41%
Dr Chandrakant Dave & Dr Darshana Dave 500,000 0.41%
Teragoal Pty Ltd 500,000 0.41%
Dr David John Ritchie & Dr Gillian Joan Ritchie < D J Ritchie Super Fund A/C> 500,000 0.41%
First Trustee Company (NZ) Limited 500,000 0.41%
Mr Peter Wade 500,000 0.41%
Leo Barry Pty Ltd 500,000 0.41%
Third Party Nominees Pty Ltd 500,000 0.41%
Tubbin Investment Pty Ltd 500,000 0.41%
Lynter Pty Ltd 500,000 0.41%
Mrs Xiangqin Li 500,000 0.41%
Jarumitoti Superannuation Fund Pty Ltd 500,000 0.41%
Mr Jason Rich 500,000 0.41%
UBS Nominees Pty Ltd 500,000 0.41%
Bresrim Nominees Pty Ltd 500,000 0.41%
Assumo (Nominees) Pty Ltd 500,000 0.41%
MHK Australia Pty Ltd 500,000 0.41%
L X X X I X Pty Ltd 485,000 0.40%
Backyard Cricket Pty Limited 400,000 0.33%
Mr Luyu Zhang 400,000 0.33%
Miss Xin Yin 400,000 0.33%
Ratt Superannuation Pty Ltd 375,000 0.31%
Gbbm Pty Limited 375,000 0.31%
All other shareholders 42.24 %


The Top 20 Shareholders of PKS hold 57.76% of shares on issue.

PKS Share Price History

Date Close Change % Change Open High Low Volume Turnover

PKS Historical Data

Download up to 20 years of share price history.


Year Closing Price (30 June) Last Trade

Offical data as published by ASX. See more Data Downloads.

Company Details

Principal Activity: To provide a proprietary subscription based Clinical Decision Support system (CDS) designed to provide health professionals with assistance in clinical decision-making tasks.

Incorporated: --

Level 5, 126 Phillip St
Sydney NSW 2000


All data on this page is supplied by the ASX, Morningstar and Market Index. Read the disclaimer.